ALIDYA™

ALIDYA™ is an injectable device specifically indicated for the prevention and treatment of gynoid lipodystrophy (cellulite).
Reduces appearance of cellulite and dimpled skin, improving overall look, and helps prevent cellulite from forming after treatment.

95.00

 Product Information

Additional information

Active substances

POLYAMINO ACID GEL, D-GLUCOPYRANOSE, MANNITOL, SODIUM ETHYLENEDIAMINETETRAACETATE (EDTA)

Manufacturer

Ghimas S.p.A.

Pack size

5 x 340mg Vials, 5 x 10ml Solvent

Strength

Delivery Guaranteed

Kinami Health ensures quick and secure delivery for clinics, hospitals, and beauty professionals. Enjoy fast and reliable shipping, ensuring your orders arrive quickly. Our secure packaging guarantees that products arrive intact and ready to use.

100% Authentic Products

We supply only genuine medical and aesthetic products directly from trusted manufacturers. Every item is quality-checked to ensure safety, effectiveness, and compliance with industry standards. Get premium products at competitive prices.

Dedicated Sales
Representative

Our sales representatives help you find the best solutions for your practice. Whether you need product recommendations, bulk pricing, or order assistance, we’re just a call or message away.

VIP Treatment

Loyal customers enjoy priority service, early access to new products, and exclusive discounts. We value your business and ensure that you get the best deals and support to grow your practice.

Long Description

Product Description

ALIDYA™ is manufactured by Ghimas S.p.a. as an anti-lipodystrophic agent specifically indicated for correcting profilometric surface alterations associated with cellulite. 

 

Each pack contains 5 x 340mg vials with powder and 5 x 10 ml vials with solvent. The solution addresses the underlying mechanisms of cellulite formation by targeting fibrous bands while improving lymphatic drainage throughout the treated area.

What is the Intended Purpose of ALIDYA™?

ALIDYA™ serves as a treatment for cellulite reduction across various body areas. This medical solution is designed to prevent and treat gynoid lipodystrophy while improving the appearance of dimpled skin. 

 

The product restores normal tissue homeostasis and enhances skin texture and firmness. ALIDYA™ is effective for treating common areas such as the buttocks, hips, and thighs, where cellulite accumulation is most prevalent in most patients. This innovative solution delivers consistent results when administered according to proper protocol.

ALIDYA™ Dosage and Administration

ALIDYA™ requires careful preparation and administration using sterile technique. Medical professionals should use an aseptic method to mix the solvent with the powder in sterile vials. The solution is administered using a 30G 4mm needle for intradermal or subcutaneous injection. 

 

Each treatment involves 0.2 ml to 0.3 ml micro-bolus injections in the subcutaneous areas. Treatment consists of weekly sessions, with most patients requiring 7–12 sessions spaced one week apart. The treated areas should be properly disinfected before administration, and a massage after injection ensures optimal results.

Ingredient Information

ALIDYA™ contains active substances, including polyamino acid gel as the primary active component. D-glucopyranose supports tissue metabolism, while mannitol serves as an osmotic regulator. 

 

Sodium ethylenediaminetetraacetate (EDTA) functions as a chelating agent, and the amino acid buffer system with bicarbonate-sodium corrector maintains proper formulation stability. These ingredients work synergistically to break down cellulite and improve skin texture throughout the treated body areas.

Storage Instructions

Proper storage ensures ALIDYA™ maintains its therapeutic efficacy. The product should be stored at room temperature (15–25°C) while protected from direct sunlight. All vials must be kept in original packaging and should not be frozen.

 

Medical facilities should maintain appropriate storage conditions to preserve product integrity and use the solution within the expiration date provided by the manufacturer.

ALIDYA™ Contraindications

ALIDYA™ is contraindicated for pregnant or breastfeeding women and patients with severe allergies or anaphylaxis history. The product should not be used in individuals with autoimmune diseases or those with severe systemic conditions. 

 

Healthcare professionals must carefully screen patients before treatment initiation to ensure safety and efficacy. Any history of allergic reactions to similar products should be thoroughly evaluated before proceeding with ALIDYA™ injections.

ALIDYA™ Precautions and Warnings

  • Important safety considerations for ALIDYA™ include avoiding sun exposure 12 hours post-treatment. 
  • No cosmetics should be applied to the treated area for 12 hours following administration. Medical professionals must screen patients for allergic reactions and follow proper sterile technique during all procedures. 
  • For deeper dermal injections, consider topical anesthesia to ensure patient comfort. 
  • Healthcare providers should inform patients about all necessary precautions to optimize treatment outcomes.

ALIDYA™ Manufacturer and Regulatory Information

ALIDYA™ is manufactured by Ghimas S.p.a., a pharmaceutical company based in Italy with extensive experience in aesthetic medicine products. The product holds CE certification, ensuring compliance with European medical device standards. 

 

Healthcare providers can order ALIDYA™ through authorized medical suppliers that guarantee product authenticity with original LOT numbers. When you order ALIDYA™, ensure proper verification of supplier credentials to maintain treatment integrity and patient safety.

FAQ

What is the Intended Purpose of ALIDYA™?

What are the Main Benefits of ALIDYA™?

What are the Side Effects of ALIDYA™?